Advia Centaur B-Type Natriuretic Peptide (Bnp) Assay
Test, Natriuretic Peptide. 510(k) K031038, from Bayer Healthcare, LLC (Tarrytown, NY). Product code NBC, class 2.
As of Nov 17, 2026, K031038 is an FDA 510(k) held by Bayer Healthcare, LLC, substantially equivalent on Jun 23, 2003 after 83 days, with 6 recalls tied to it in FDA's recall database.
- Substantially equivalent: Jun 23, 2003
- Review time: 83 days
- Recalls: 6
- Cited as a predicate by: 3 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFFor in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur® System. This assay is indicated for the measurement of plasma BNP as an aid in the diagnosis of heart failure. This assay is not intended for use on any other system. Office of In Vitro Diagnostic Device Evaluation and Safety 510(k) K 0 31 0 38
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- K003475K003475
- Triage B-Type Natriuretic Peptide (Bnp) Test, Catalog #98000K010266 · Biosite Incorporated · Mar 16, 2001
Cited as a Predicate
3 later 510(k) summaries name this device as a predicate- St Aia-Pack BnpK192380 · Fujirebio Diagnostics,Inc. · Aug 24, 2020
- ACS:180 And Advia Centaur B-Type Natriuretic Peptide (Bnp) AssaysK043228 · Bayer Healthcare, LLC · Apr 22, 2005
- ACS:180 And Advia Centaur B-Type Natriuretic Peptide (Bnp) AssaysK040425 · Bayer Healthcare, LLC · Jun 14, 2004
Recalls
Recalls FDA ties to K031038, newest first; each opens FDA's recall record| Dec 18, 2017 | Z-2053-2018In certain scenarios the ADVIA Centaur CP, XP and XPT immunoassay analyzers may exhibit reduced dilution recovery or become inoperable when used with Multi-Diluent 15 and certain lots of BNP and TSH3RUL Assays. | Open, Classified |
| Oct 6, 2014 | Z-0229-2015Siemens Healthcare Diagnostics has confirmed that approximately 2000 ReadyPacks from the ADVIA Centaur Systems BNP reagent contains an ADVIA Centaur Systems FT4 human-readable side label. | Terminated |
| Jun 23, 2014 | Z-2150-2014Complaints of failed calibration. | Terminated |
| Jun 23, 2014 | Z-2149-2014Complaints of failed calibration. | Terminated |
| Nov 14, 2012 | Z-0506-2013Operating range of the ADVIA Centaur systems is 18C to 30C (64.4F to 86.0F), a change in room temperature may increase or decrease assay results, depending on the specific assay and ADVIA Centaur system used. | Terminated |
| Jul 25, 2012 | Z-2313-2012Decrease in onboard dilution recovery when using Multi-Diluent 1 that has been stored on board the ADVIA Centaur and ADVIA Centaur XP systems for for BNP and TSH3 Ultra assays | Terminated |
Other NBC Clearances
The newest 510(k)s for the same product code; their median review was 257 days; see every NBC device- Access BNP IIK262597 · Beckman Coulter, Inc. · Oct 20, 2026
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity iK253539 · Axis-Shield Diagnostics, Ltd. · Feb 18, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- Access NT-proBNPK232164 · Beckman Coulter, Inc. · Apr 12, 2024
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 1, 2003
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files